-+ 0.00%
-+ 0.00%
-+ 0.00%

Inventiva SA Announces Progress on Phase III NATiV3 Trial for MASH Treatment at Canaccord Genuity Conference

Reuters·08/11/2025 20:01:11

Please log in to view news